Profile picture

Professor Tim Friede

University Medical Centre of Gottingen (UMG), Goettingen (Germany)
Follow
Biography
Since January 2010 Tim Friede is Professor of Biostatistics at the University Medical Center Göttingen where he heads up the Department of Medical Statistics. He graduated in Mathematics (Dipl.-Math.) from the University of Karlsruhe and obtained a PhD (Dr.sc.hum.) from the Faculty of Medicine at the University of Heidelberg. In 2001 he joined the Department of Mathematics and Statistics at Lancaster University as NHS Training Fellow in Medical Statistics and was later promoted to Lecturer in Biostatistics. From 2004 on he worked for Novartis Pharma AG, Basel before joining Warwick Medical School as Associate Professor of Medical Statistics in October 2006.
Logo ESC

Contributor content

Effect of anti-fibrotic therapy on regression of myocardial fibrosis after TAVI: design and rationale of the Reduce-MFA DZHK25 trial
Journal
Effect of anti-fibrotic therapy on regression of myocardial fibrosis after TAVI: design and rationale of the Reduce-MFA DZHK25 trial
12 May 2026
Baseline characteristics in the TransitionCHF study: asymptomatic patients with heart failure and reduced ejection fraction
Journal
Baseline characteristics in the TransitionCHF study: asymptomatic patients with heart failure and reduced ejection fraction
21 January 2026
Erythropoiesis-stimulating agents in anaemic patients with HF–a lost cause?
Journal
Erythropoiesis-stimulating agents in anaemic patients with HF–a lost cause?
21 January 2026
Heart failure therapy in patients with advanced cancer receiving specialized palliative care (EMPATICC trial)
Journal
Heart failure therapy in patients with advanced cancer receiving specialized palliative care (EMPATICC trial)
30 August 2025
Randomized Investigation of Heart Failure Therapy in Patients with Advanced Cancer at Risk of Cardiac Wasting: Rationale and Design of the EMPATICC Trial
Journal
Randomized Investigation of Heart Failure Therapy in Patients with Advanced Cancer at Risk of Cardiac Wasting: Rationale and Design of the EMPATICC Trial
26 August 2025
Rationale and Design of the Randomized ‘Early Ventricular Assist Device’—Trial (VAD-DZHK3)
Journal
Rationale and Design of the Randomized ‘Early Ventricular Assist Device’—Trial (VAD-DZHK3)
20 July 2025
Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts
Journal
Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts
8 October 2024
Exercise Training in Left Ventricular Assist Device Patients: Protocol of an Individual Participant Data Meta-Analysis
Journal
Exercise Training in Left Ventricular Assist Device Patients: Protocol of an Individual Participant Data Meta-Analysis
25 September 2024
A simplified approach to discriminate between healthy subjects and patients with heart failure using cardiac magnetic resonance myocardial deformation imaging
Journal
A simplified approach to discriminate between healthy subjects and patients with heart failure using cardiac magnetic resonance myocardial deformation imaging
12 September 2024
Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trial
Journal
Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trial
26 August 2024